Search Details

Word: astrazeneca (lookup in dictionary) (lookup stats)
Dates: all
Sort By: most recent first (reverse)


Usage:

CRESTOR Graham cited reports that some patients on Crestor, one of the newest anticholesterol statins, have suffered kidney failure. The drug's manufacturer, AstraZeneca, says the prescription drug is safe as long as it is used properly...

Author: /time Magazine | Title: Health: How Safe Are They? | 11/29/2004 | See Source »

...pharmaceutical blacklist, warning Canadian pharmacies that if they sell drugs to Americans, Pfizer will halt supplies of all its products. The company ordered Canadian wholesale distributors to prepare reports itemizing past and present sales of its products by individual drugstores. Pfizer declined to comment to TIME. Four other companies--AstraZeneca, GlaxoSmithKline, Eli Lilly and Wyeth--have taken steps to reduce Canadian sales...

Author: /time Magazine | Title: Why Drugs Cost So Much / The Issues '04: Why We Pay So Much for Drugs | 2/2/2004 | See Source »

...nearly fivefold increase from $8.7 billion in 1995. Seventeen of the 20 largest drug companies worldwide now make drugs in Ireland, largely because of tax incentives. Pfizer's Lipitor for cholesterol, the largest-selling drug in the world, is made in Ireland. So too is Viagra, for erectile dysfunction. AstraZeneca's Nexium, for heartburn and acid reflux, comes from Sweden, France and other countries. TAP Pharmaceutical Products' Prevacid, another brand prescribed for heartburn and acid reflux, comes from Japan. Because of the rapid rise in drug imports, especially from Ireland, Britain and Germany, the U.S. balance of trade in pharmaceuticals...

Author: /time Magazine | Title: Why Drugs Cost So Much / The Issues '04: Why We Pay So Much for Drugs | 2/2/2004 | See Source »

Enough To Make You Sick AstraZeneca's drug pipeline is looking dry. First its cholesterol drug failed clinical tests, then last week the lung-cancer drug Iressa, with forecast annual sales of $2 billion, followed suit...

Author: /time Magazine | Title: For Fourtou, Breaking Up is Hard to Do | 8/25/2002 | See Source »

...contract with Mercury Asset Management, which was acquired by Merrill in 1997. After almost two months in court, Merrill settled, paying Unilever a reported $115 million. Unhappily for Merrill, the outcome of these disputes has caught the attention of some of its other clients - including the British drugmaker AstraZeneca and England's Surrey County Council, which are said to be considering court action as well...

Author: /time Magazine | Title: Brazil | 8/12/2002 | See Source »

Previous | 1 | 2 | 3 | 4 | 5 | Next